7Baggers
 brokerages set nkarta, inc. (nasdaq:nktx) target price at $13.60  MarketBeat Sun, 21 Sep 2025 08:02:26 GMT
 Brokerages Set Nkarta, Inc. (NASDAQ:NKTX) PT at $13.60  MarketBeat Sun, 21 Sep 2025 07:00:00 GMT
 published on: 2025-09-15 05:49:20  newser.com Mon, 15 Sep 2025 10:49:20 GMT
 published on: 2025-09-14 11:47:29  newser.com Sun, 14 Sep 2025 16:47:29 GMT
 nuveen llc purchases shares of 140,113 nkarta, inc. $nktx  MarketBeat Thu, 11 Sep 2025 17:52:19 GMT
 nuveen llc invests $258,000 in nkarta, inc. $nktx  MarketBeat Thu, 11 Sep 2025 07:00:00 GMT
 nuveen llc purchases new holdings in nkarta, inc. $nktx  MarketBeat Wed, 10 Sep 2025 23:20:42 GMT
 nuveen llc buys new stake in nkarta, inc. $nktx  MarketBeat Wed, 10 Sep 2025 09:25:30 GMT
 nuveen llc invests $258,000 in nkarta, inc. $nktx  MarketBeat Mon, 08 Sep 2025 08:42:59 GMT
 nuveen llc invests $258,000 in nkarta, inc. $nktx  Defense World Sat, 06 Sep 2025 07:28:45 GMT
 published on: 2025-09-05 09:48:08  Newser Fri, 05 Sep 2025 14:48:08 GMT
 published on: 2025-09-05 01:51:09  Newser Fri, 05 Sep 2025 06:51:09 GMT
 nkarta, inc. reports q2 2025 financial results  MSN Wed, 03 Sep 2025 16:02:39 GMT
 Nkarta to Participate in a September Investor Conference  GlobeNewswire Tue, 02 Sep 2025 07:00:00 GMT

Nkarta, Inc
(NASDAQ:NKTX) 

NKTX stock logo

Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific p...

Founded: 2015
CEO: Paul J. Hastings  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends